CLINICAL_TRIALS
trial_result
· 2015-05-20
Clinical Trial Update: A Twelve Week Safety and Efficacy Study in Rosacea [Phase 2]
Summary
A 12-week Phase 2 trial assessing safety and efficacy in papulopustular rosacea has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Maruho Co., Ltd. | Conditions: Papulopustular Rosacea | Phase 2 | Status: COMPLETED